ARRY
Price
$4.43
Change
-$0.51 (-10.32%)
Updated
Apr 3 closing price
Capitalization
2.22B
39 days until earnings call
IBRX
Price
$2.85
Change
-$0.11 (-3.70%)
Updated
Apr 4, 10:48 AM (EDT)
Capitalization
2.53B
34 days until earnings call
Ad is loading...

ARRY vs IBRX

Header iconARRY vs IBRX Comparison
Open Charts ARRY vs IBRXBanner chart's image
Array Technologies
Price$4.43
Change-$0.51 (-10.32%)
Volume$4.71M
Capitalization2.22B
ImmunityBio
Price$2.85
Change-$0.11 (-3.70%)
Volume$4.45K
Capitalization2.53B
ARRY vs IBRX Comparison Chart
Loading...
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARRY vs. IBRX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARRY is a StrongBuy and IBRX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (IBRX: $2.97)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IBRX’s FA Score shows that 1 FA rating(s) are green while.

  • IBRX’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARRY’s TA Score shows that 4 TA indicator(s) are bullish while IBRX’s TA Score has 4 bullish TA indicator(s).

  • ARRY’s TA Score: 4 bullish, 6 bearish.
  • IBRX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, IBRX is a better buy in the short-term than ARRY.

Price Growth

IBRX (@Biotechnology) experienced а -11.61% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.48%. For the same industry, the average monthly price growth was -15.36%, and the average quarterly price growth was -17.16%.

Reported Earning Dates

IBRX is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-9.48% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IBRX($2.54B) has a higher market cap than ARRY($2.22B). IBRX YTD gains are higher at: 16.016 vs. ARRY (-26.656). ARRY has higher annual earnings (EBITDA): 276M vs. IBRX (-264.43M). ARRY has more cash in the bank: 249M vs. IBRX (150M). IBRX has less debt than ARRY: IBRX (504M) vs ARRY (730M). ARRY has higher revenues than IBRX: ARRY (1.58B) vs IBRX (14.7M).
ARRYIBRXARRY / IBRX
Capitalization2.22B2.54B88%
EBITDA276M-264.43M-104%
Gain YTD-26.65616.016-166%
P/E Ratio26.23N/A-
Revenue1.58B14.7M10,728%
Total Cash249M150M166%
Total Debt730M504M145%
FUNDAMENTALS RATINGS
ARRY vs IBRX: Fundamental Ratings
ARRY
IBRX
OUTLOOK RATING
1..100
5963
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
3
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
8753
P/E GROWTH RATING
1..100
25100
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IBRX's Valuation (3) in the Biotechnology industry is significantly better than the same rating for ARRY (98). This means that IBRX’s stock grew significantly faster than ARRY’s over the last 12 months.

IBRX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ARRY (100). This means that IBRX’s stock grew similarly to ARRY’s over the last 12 months.

IBRX's SMR Rating (100) in the Biotechnology industry is in the same range as ARRY (100). This means that IBRX’s stock grew similarly to ARRY’s over the last 12 months.

IBRX's Price Growth Rating (53) in the Biotechnology industry is somewhat better than the same rating for ARRY (87). This means that IBRX’s stock grew somewhat faster than ARRY’s over the last 12 months.

ARRY's P/E Growth Rating (25) in the Biotechnology industry is significantly better than the same rating for IBRX (100). This means that ARRY’s stock grew significantly faster than IBRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARRYIBRX
RSI
ODDS (%)
Bullish Trend 1 day ago
88%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 18 days ago
80%
Bullish Trend 9 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ABPCX11.64N/A
N/A
AB Sustainable Thematic Bal Port C
FVDKX37.15N/A
N/A
Fidelity Value Discovery K
LSCRX20.51N/A
N/A
Loomis Sayles Small Cap Value Retail
HFDRX18.09N/A
N/A
Hartford Schroders US MidCap Opps R3
SGENX70.49-1.45
-2.02%
First Eagle Global A